Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enfusion Inc Cl A (NY: ENFN )

10.32 -0.04 (-0.39%)
Streaming Delayed Price Updated: 10:58 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enfusion Inc Cl A

< Previous 1 2 3 4 Next >
Enfusion To Present at Upcoming Investor Events
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Third Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation
From Enfusion, Inc.
Via Business Wire
A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
Via Benzinga
Earnings Outlook For Enfusion
Via Benzinga
JP Morgan Downgrades Enfusion: Here's What You Need To Know
Via Benzinga
Enfusion Announces Date of Third Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024
ENFN stock results show that Enfusion missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Enfusion Announces Second Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Second Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion To Present at Upcoming Investor Events
From Enfusion, Inc.
Via Business Wire
ENFN Stock Earnings: Enfusion Beats EPS, Beats Revenue for Q1 2024
ENFN stock results show that Enfusion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Enfusion Announces First Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of First Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
Equities have only become more expensive, but investors should still lookout for the most undervalued under-$10 stocks to buy in April. 
Via InvestorPlace
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
From Enfusion
Via Business Wire
Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
U.S. equities market is rallying, but there are still interesting investments to make, especially for these strong-buy stocks under $10. 
Via InvestorPlace
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results
From Enfusion, Inc.
Via Business Wire
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, March 2
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 26 through March 1. 
Via Talk Markets
Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock
Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2024 with slower growth than Street estimates due to company-specific... 
Via Benzinga
Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion to Host Investor Day on March 19, 2024
From Enfusion, Inc.
Via Business Wire
This Analyst With 84% Accuracy Rate Sees Around 13% Upside In Darden Restaurants - Here Are 5 Stock Picks For 2023 From Wall Street's Most Accurate Analysts
U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The Dow closed the year with a 13.7% gain, while the Nasdaq Composite surged 43.4% to record its... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.